[go: up one dir, main page]

BRPI0411749A - método para a inibição do crescimento de bactérias resistentes a antibióticos pelo uso de pentano-1,5-diol - Google Patents

método para a inibição do crescimento de bactérias resistentes a antibióticos pelo uso de pentano-1,5-diol

Info

Publication number
BRPI0411749A
BRPI0411749A BRPI0411749A BRPI0411749A BR PI0411749 A BRPI0411749 A BR PI0411749A BR PI0411749 A BRPI0411749 A BR PI0411749A BR PI0411749 A BRPI0411749 A BR PI0411749A
Authority
BR
Brazil
Prior art keywords
diol
composition
resistant bacteria
pentane
growth
Prior art date
Application number
Other languages
English (en)
Inventor
Jan Faergemann
Thomas Hedner
Original Assignee
Ambria Dermatology Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambria Dermatology Ab filed Critical Ambria Dermatology Ab
Publication of BRPI0411749A publication Critical patent/BRPI0411749A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
    • Y10T442/2525—Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

"MéTODO PARA A INIBIçãO DO CRESCIMENTO DE BACTéRIAS RESISTENTES A ANTIBIóTICOS PELO USO DE PENTANO-1,5-DIOL". Um método para a inibição do crescimento de bactérias multi-resistentes compreende a administração tópica de uma composição farmacêutica que compreende 15% em peso ou mais de pentano-1,5-diol e um veículo farmaceuticamente aceitável. Também é revelado um método de preparação de um medicamento correspondente. Um método de desinfecção de uma superfície contaminada com bactérias multi-resistentes compreende o fornecimento de uma composição desinfetante que compreende 15% ou mais em peso de pentano-1,5-diol e um veículo adequado, aplicação da referida composição à superfície; opcionalmente, a manutenção da composição em contato com a superfície por um período de tempo de 5 min a 24 horas em temperatura ambiente e o enxágüe da referida superfície com água ou uma composição detergente aquosa. Também é revelado o uso da composição bacteriostática correspondente.
BRPI0411749 2003-06-26 2004-06-23 método para a inibição do crescimento de bactérias resistentes a antibióticos pelo uso de pentano-1,5-diol BRPI0411749A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0301862A SE0301862D0 (sv) 2003-06-26 2003-06-26 Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
PCT/SE2004/001001 WO2004112765A1 (en) 2003-06-26 2004-06-23 Method for inhibiting the growth of antibiotic-resistant of bacteria by using pentane-1,5-diol

Publications (1)

Publication Number Publication Date
BRPI0411749A true BRPI0411749A (pt) 2006-08-08

Family

ID=27656597

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411749 BRPI0411749A (pt) 2003-06-26 2004-06-23 método para a inibição do crescimento de bactérias resistentes a antibióticos pelo uso de pentano-1,5-diol

Country Status (16)

Country Link
US (1) US7973080B2 (pt)
EP (1) EP1635802B1 (pt)
JP (1) JP4824553B2 (pt)
KR (1) KR20060103817A (pt)
CN (1) CN1812775B (pt)
AT (1) ATE403421T1 (pt)
AU (1) AU2004249102A1 (pt)
BR (1) BRPI0411749A (pt)
CA (1) CA2529287A1 (pt)
DE (1) DE602004015597D1 (pt)
DK (1) DK1635802T3 (pt)
ES (1) ES2313038T3 (pt)
PL (1) PL1635802T3 (pt)
RU (1) RU2355392C9 (pt)
SE (1) SE0301862D0 (pt)
WO (1) WO2004112765A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2586815A1 (en) 2004-11-29 2006-06-01 Ambria Dermatology Ab A composition comprising at least 3 different diols
CA2630881A1 (en) * 2005-11-29 2007-06-07 Ambria Dermatology Ab Use of a composition comprising pentane-1, 5-diol as deodorant
SE533425C2 (sv) * 2008-07-07 2010-09-21 Ambria Dermatology Ab Antimikrobiell sammansättning
FR2940281B1 (fr) 2008-12-22 2011-04-01 Fabre Pierre Dermo Cosmetique Ester de diol et d'acide gras polyinsature comme agent anti-acne
CN103816165B (zh) * 2014-03-11 2019-03-01 北京德默高科医药技术有限公司 一种治疗痤疮的组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG50568A1 (en) * 1989-01-31 1998-07-20 Novartis Ag High salt content rapid disinfection solution for contact lenses
SE464060B (sv) * 1989-06-13 1991-03-04 Gunnar Swanbeck Anvaendning av pentandiol eller hexandiol foer framstaellning av ett medel foer behandling av infektioner orsakade av herpesvirus
US5369129A (en) * 1989-06-13 1994-11-29 Hydro Pharma Ab Preparation of topical treatment of infections caused by virus, bacteria and fungi
SE500777C2 (sv) 1992-04-14 1994-08-29 Hydro Pharma Ab Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
US5370876A (en) * 1993-01-08 1994-12-06 Microbarriers Antimicrobial protective skin composition and method for protecting skin from body fluids
US5879690A (en) * 1995-09-07 1999-03-09 Perricone; Nicholas V. Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
GB9626513D0 (en) * 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
US6548074B1 (en) 1999-07-22 2003-04-15 Elizabeth Arden Co., Division Of Conopco, Inc. Silicone elastomer emulsions stabilized with pentylene glycol
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US20020192273A1 (en) * 2001-06-15 2002-12-19 Teri Buseman Therapeutic patch useful for the treatment of hemorrhoids

Also Published As

Publication number Publication date
EP1635802A1 (en) 2006-03-22
PL1635802T3 (pl) 2009-01-30
AU2004249102A1 (en) 2004-12-29
EP1635802B1 (en) 2008-08-06
JP2007521265A (ja) 2007-08-02
RU2355392C2 (ru) 2009-05-20
ATE403421T1 (de) 2008-08-15
US7973080B2 (en) 2011-07-05
DK1635802T3 (da) 2008-12-08
CA2529287A1 (en) 2004-12-29
RU2005140049A (ru) 2006-07-27
RU2355392C9 (ru) 2009-07-27
DE602004015597D1 (de) 2008-09-18
CN1812775B (zh) 2011-07-27
WO2004112765A1 (en) 2004-12-29
JP4824553B2 (ja) 2011-11-30
SE0301862D0 (sv) 2003-06-26
CN1812775A (zh) 2006-08-02
US20070020322A1 (en) 2007-01-25
KR20060103817A (ko) 2006-10-04
ES2313038T3 (es) 2009-03-01

Similar Documents

Publication Publication Date Title
ECSP088869A (es) Derivados de 2-pirazinona para el tratamiento de enfermedades o condiciones en donde resulta beneficiosa la inhibición de la actividad de la elastasa neutrofílica
NO20051986L (no) Sammenhengende frigivelsesavlevering av amfetaminsalter.
CR10838A (es) Derivados de 2,3-dihidroimidazol [1,2-c] quinazolina sustituidos, de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis
NO20065904L (no) Terapeutiske forbindelser
ECSP055531A (es) "nuevos derivados de glicósido de tiofeno, metodos para la preparacion de los mismos, medicamentos que comprenden dichos compuestos, y su uso"
UY28510A1 (es) Compuestos quimicos
UY30025A1 (es) Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones.
UY27446A1 (es) Nuevos compuestos
NO20064201L (no) Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
AR029383A1 (es) Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes
ECSP055747A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
AR029175A1 (es) Derivados 2-amino-fenilpurina, un proceso para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la preparacion de un medicamento
BR0311460A (pt) Composição farmacêutica de liberação modificada, uso de uma formulação, e, método para tratar um distúrbio cardiovascular em um paciente
BR0213612A (pt) Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição
UA94901C2 (ru) Антибактериальные производные пиперидина
UY28040A1 (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos.
CR6726A (es) Compuestos azapoliciclicos condensados con arilo
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
ECSP088763A (es) Nuevas combinaciones terapéuticas para el tratamiento de la depresión
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
HN1999000183A (es) Preparado farmaceuticos de moxifloxacina
AR054129A1 (es) Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7
AR044200A1 (es) Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.